Ubogu EE - Search Results

1

Fibulin-5 mutation featuring Charcot-Marie-Tooth disease, joint hyperlaxity, and scoliosis.

Kazamel M, Lopez MA, Bebin M, Bowling K, Korf BR, Barsh GS, Cooper GM, Hurst ACE, Ubogu EE. Kazamel M, et al. Among authors: ubogu ee. Neurol Genet. 2020 Jun 25;6(4):e476. doi: 10.1212/NXG.0000000000000476. eCollection 2020 Aug. Neurol Genet. 2020. PMID: 32802946 Free PMC article. No abstract available.

2

A Novel Dynamin 2 Mutation Causing Dominant Intermediate Charcot-Marie-Tooth Neuropathy: Case Report.

San Luis CV, Schwartzlow C, Nozaki K, Ubogu EE. San Luis CV, et al. Among authors: ubogu ee. J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221117801. doi: 10.1177/23247096221117801. J Investig Med High Impact Case Rep. 2022. PMID: 35993408 Free PMC article.

3

Biology of the human blood-nerve barrier in health and disease.

Ubogu EE. Ubogu EE. Exp Neurol. 2020 Jun;328:113272. doi: 10.1016/j.expneurol.2020.113272. Epub 2020 Mar 3. Exp Neurol. 2020. PMID: 32142802 Free PMC article. Review.

4

Disruption of Endosomal Sorting in Schwann Cells Leads to Defective Myelination and Endosomal Abnormalities Observed in Charcot-Marie-Tooth Disease.

McLean JW, Wilson JA, Tian T, Watson JA, VanHart M, Bean AJ, Scherer SS, Crossman DK, Ubogu E, Wilson SM. McLean JW, et al. J Neurosci. 2022 Jun 22;42(25):5085-5101. doi: 10.1523/JNEUROSCI.2481-21.2022. Epub 2022 May 19. J Neurosci. 2022. PMID: 35589390 Free PMC article.

5

Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.

Dong C, Greathouse KM, Beacham RL, Palladino SP, Helton ES, Ubogu EE. Dong C, et al. Among authors: ubogu ee. Exp Neurol. 2017 Jun;292:35-45. doi: 10.1016/j.expneurol.2017.02.012. Epub 2017 Feb 16. Exp Neurol. 2017. PMID: 28215575 Free PMC article.

6

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team. Nowak RJ, et al. Neurology. 2022 Jan 25;98(4):e376-e389. doi: 10.1212/WNL.0000000000013121. Neurology. 2022. PMID: 34857535 Free PMC article.

7

Hirayama Disease: An Important Cause of Focal Hand Weakness in Young Adults.

Jiang N, Ubogu EE. Jiang N, et al. Among authors: ubogu ee. J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211001646. doi: 10.1177/23247096211001646. J Investig Med High Impact Case Rep. 2021. PMID: 33733902 Free PMC article.

8

An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies.

Yosef N, Ubogu EE. Yosef N, et al. Among authors: ubogu ee. Cell Mol Neurobiol. 2013 Mar;33(2):175-86. doi: 10.1007/s10571-012-9882-7. Epub 2012 Oct 27. Cell Mol Neurobiol. 2013. PMID: 23104242 Free PMC article.

9

The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.

Ubogu EE. Ubogu EE. J Vasc Res. 2013;50(4):289-303. doi: 10.1159/000353293. Epub 2013 Jul 6. J Vasc Res. 2013. PMID: 23839247 Free PMC article. Review.

10

The Human Blood-Nerve Barrier Transcriptome.

Palladino SP, Helton ES, Jain P, Dong C, Crowley MR, Crossman DK, Ubogu EE. Palladino SP, et al. Among authors: ubogu ee. Sci Rep. 2017 Dec 12;7(1):17477. doi: 10.1038/s41598-017-17475-y. Sci Rep. 2017. PMID: 29234067 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters